Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

LakeShore Biopharma Co., Ltd LSB

Full chart Compare
Set alert

Price alert · LSB

All alert types
0.63 USD 0.00 (+0.00%)

At closeSep 19, 2025, 4:00 PM EDT

0.627 Day range 0.7899
0.5743 52-week range 0.855
YTD
0.00%
1 year
0.00%

Financial health

Altman Z-Score

-2.72 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -18.9×
FY 2021: -93.1×FY 2022: -33287×FY 2023: -58.4×FY 2024: -12.9×FY 2025: -18.9×
FY 2021 5y median -58.4× FY 2025
P/S 3.1×
FY 2021: 69.5×FY 2022: 36.1×FY 2023: 12.4×FY 2024: 9.8×FY 2025: 3.1×
FY 2021 5y median 12.4× FY 2025
P/B 3.8×
FY 2021: 23.0×FY 2022: 27.1×FY 2023: 11.7×FY 2024: 9.6×FY 2025: 3.8×
FY 2021 5y median 11.7× FY 2025
P/FCF -13.7×
FY 2021: -50.8×FY 2022: -60.6×FY 2023: -35.5×FY 2024: -16.5×FY 2025: -13.7×
FY 2021 5y median -35.5× FY 2025
EV/EBITDA -47.1×
FY 2021: -150×FY 2022: -272×FY 2023: -112×FY 2024: -15.7×FY 2025: -47.1×
FY 2021 5y median -112× FY 2025
EV/Sales 3.7×
FY 2021: 68.0×FY 2022: 36.3×FY 2023: 12.6×FY 2024: 10.1×FY 2025: 3.7×
FY 2021 5y median 12.6× FY 2025
FCF Yield -7.3%
FY 2021: -2.0%FY 2022: -1.6%FY 2023: -2.8%FY 2024: -6.1%FY 2025: -7.3%
FY 2021 5y median -2.8% FY 2025

Profitability

Gross Margin 82.5%
FY 2021: 76.8%FY 2022: 75.9%FY 2023: 77.7%FY 2024: 79.5%FY 2025: 82.5%
FY 2021 5y median 77.7% FY 2025
Operating Margin -14.0%
FY 2021: -49.0%FY 2022: -23.7%FY 2023: -20.3%FY 2024: -77.7%FY 2025: -14.0%
FY 2021 5y median -23.7% FY 2025
Net Margin -16.3%
FY 2021: -74.6%FY 2022: -47.1%FY 2023: -21.2%FY 2024: -75.6%FY 2025: -16.3%
FY 2021 5y median -47.1% FY 2025
ROE -20.0%
FY 2021: -24.7%FY 2022: -35.3%FY 2023: -20.0%FY 2024: -74.1%FY 2025: -20.0%
FY 2021 5y median -24.7% FY 2025
ROIC -9.2%
FY 2021: -32.1%FY 2022: -11.0%FY 2023: -11.1%FY 2024: -41.0%FY 2025: -9.2%
FY 2021 5y median -11.1% FY 2025
ROA -7.3%
FY 2021: -209935.3%FY 2022: -117.7%FY 2023: -8.5%FY 2024: -28.6%FY 2025: -7.3%
FY 2021 5y median -28.6% FY 2025

Growth (YoY)

Revenue 7.2%
FY 2021: 0.0%FY 2022: 95.7%FY 2023: 36.6%FY 2024: -16.6%FY 2025: 7.2%
FY 2021 FY 2025
Operating Income 80.6%
FY 2021: 0.0%FY 2022: 5.5%FY 2023: -17.2%FY 2024: -219.9%FY 2025: 80.6%
FY 2021 FY 2025
EPS (diluted) 76.8%
FY 2021: 0.0%FY 2022: 99.7%FY 2023: -10062.2%FY 2024: -115.4%FY 2025: 76.8%
FY 2021 FY 2025
Free Cash Flow 59.1%
FY 2021: 0.0%FY 2022: 14.8%FY 2023: 20.0%FY 2024: -41.7%FY 2025: 59.1%
FY 2021 FY 2025

Financial Health

Current Ratio 1.0×
FY 2021: 2.1×FY 2022: 5362×FY 2023: 1.6×FY 2024: 1.1×FY 2025: 1.0×
FY 2021 5y median 1.6× FY 2025
Quick Ratio 0.7×
FY 2021: 1.9×FY 2022: 4194×FY 2023: 1.3×FY 2024: 0.9×FY 2025: 0.7×
FY 2021 5y median 1.3× FY 2025
Debt / Equity 0.8×
FY 2021: 0.0×FY 2022: 0.6×FY 2023: 0.7×FY 2024: 0.7×FY 2025: 0.8×
FY 2021 5y median 0.7× FY 2025
Net Debt / EBITDA -8.0×
FY 2021: 3.2×FY 2022: -1.6×FY 2023: -1.7×FY 2024: -0.5×FY 2025: -8.0×
FY 2021 5y median -1.6× FY 2025
Interest Coverage -5.5×
FY 2021: -4.2×FY 2022: -43.8×FY 2023: -4.5×FY 2024: -10.1×FY 2025: -5.5×
FY 2021 5y median -5.5× FY 2025

Dividends

Dividend Yield 0.0%
FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2021 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2021 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-03-31